Homepage  
SymptomsDiseasesGenetestsShipmentSampleContactQuality
   
 


Fabry disease
301500


Pedigree


Diagnostic
strategy


Forms


Print page


Sprache
wechseln

Fabry disease

Clinical feature: 

Definition: This X-linked disorder is a consequence of deficient activity of lysosomal alpha-glactosidase A, which results in accumulation of ceramide trihexoside in multiple tissues.

Pathogenesis: The accumulation of ceramide in different cells results in organ dysfuncion.Kidneys: Moderate proteinuria, renal insufficiency, dialysis.Heart: Cardiomegaly, coronary artery disease, conduction abnormalities.Nervous system: Acroparethesias, hypohidrosis, gastrointestinal problems.Vasculture: Angiokeratoma, stroke, vertigo, deafness.Eyes: Corneal opacity.

Epidemiology: The disease is panethnic, and estimates of incidence range from about 1 in 40,000 to 60,000 males.

Diagnostics: 

Strategy: Along with a thorough investigationof all affected organs the determination of galactosidase A activity in plasma or leucocytes is in male patients significant for the diagnosis. To identify heterozygous female patients it is necessary to perform molecular investigation.

Systematic link table: 

Lysosomal storage disease
Cystinosis
CTNS
Fabry disease
GLA
Infantile sialic acid storage disorder
SLC17A5
Salla disease
SLC17A5

Literature: 

Grünfeld JP et al. (2002) Anderson-Fabry disease: its place among other genetic causes of renal disease.
Pastores GM et al. (2002) Biochemical and molecular genetic basis of Fabry disease.
Branton M et al. (2002) Natural history and treatment of renal involvement in Fabry disease.